Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 4, 2026Journal of Clinical Oncology

Integrating pharmacists into uro-oncology care: Evaluation of patient satisfaction and well-being.

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJ. FischerCACan AydogduFKFrederik Kolligs

Discussion

Loading...

Member takes

Overview

Trial evaluates pharmacist integration effects on patient satisfaction and well-being in uro-oncology care, suggesting improved outcomes.

Key Points

  • This trial aimed to evaluate the impact of pharmacist integration into uro-oncology care on patient satisfaction and health-related quality of life.
  • Prospective, investigator-initiated, single-center pre-post trial
  • Included adult outpatients with urothelial, prostate, or renal cell cancer
  • Pharmacist involvement included medication reconciliation and symptom assessments over 12 weeks
  • Patient satisfaction improved significantly after 4 weeks with pharmacist support, rising from mean 3.9 to 4.5 (p < 0.001)
  • Continued improvement observed at 12 weeks, mean satisfaction increased to 4.7 (p < 0.001)
  • Emotional functioning burden significantly decreased in the intervention phase (p = 0.005)
  • While health-related quality of life remained stable, functional scales showed trends favoring the intervention phase

Cite This Study

Fischer et al. (2026) studied this question.

synapsesocial.com/papers/69a7ccf7d48f933b5eed8f56https://doi.org/10.1200/jco.2026.44.7_suppl.714
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 14CPS-037 Integration of the pharmacist in the multidisciplinary committee of uro-oncological pathology2024
  2. 2Development of an innovative clinical pharmacy service in a urology surgical unit: a new initiative from Qatar2024 · 3 citations
  3. 3Evaluation of pain and quality of life in cancer patients using a multidimensional tool: A study on the impact of pharmacist interventions2026
  4. 4Pharmacist-led continuity of care interventions for patients receiving oral anticancer therapy: a systematic review and meta-analysis2026
  5. 5Impact of pharmacist managed oral epidermal growth factor receptor inhibitors2024 · 1 citations